Global Recombinant Protein Drug Market Professional Survey Report 2016

Published: Jun, 2016 | Pages: 109 | Publisher: QYResearch
Industry: Chemicals & Materials | Report Format: Electronic (PDF)

This report mainly covers the following

Product types including
    Recombinant Insulin
    Recombinant Human Interferon (rhIFN)
    Recombinant Human Erythropoietin (rhEPO)
    Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
    Recombinant Human Growth Hormone (rhGH)
    Recombinant Human Follicle-stimulating Hormone (rhFSH)
    Others

The segment applications including
    Hospital use
    Clinic use
    Household

Segment regions including (the separated region report can also be offered)
    North America
    Europe
    Japan
    China
    Southeast Asia
    India

The players list (Partly, Players you are interested in can also be added)
    Novo Nordisk
    Amgen
    Sanofi
    Eli Lilly
    Merck Serono
    Ortho Biotech
    Roche
    Kyowa Hakko Kirin
    Pharmingen
    Abcam
    GenSci
    SL PHARM
    Shenzhen Neptunus Interlong Bio-Technique Co., Ltd.
    Anhui Anke Biotechnology
    NCPC
    Heng Rui
    Changchun High & New Technology Industry (Group) Inc
    Livzon Pharmaceutical Group Inc
With 18 top producers.

Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

 Table of Contents


1 Industry Overview of Recombinant Protein Drug
    1.1 Definition and Specifications of Recombinant Protein Drug
        1.1.1 Definition of Recombinant Protein Drug
        1.1.2 Specifications of Recombinant Protein Drug
    1.2 Classification of Recombinant Protein Drug
        1.2.1 Recombinant Insulin
        1.2.2 Recombinant Human Interferon (rhIFN)
        1.2.3 Recombinant Human Erythropoietin (rhEPO)
        1.2.4 Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF)
        1.2.5 Recombinant Human Growth Hormone (rhGH)
        1.2.6 Recombinant Human Follicle-stimulating Hormone (rhFSH)
        1.2.7 Others
    1.3 Applications of Recombinant Protein Drug
        1.3.1 Hospital use
        1.3.2 Clinic use
        1.3.3 Household
    1.4 Industry Chain Structure of Recombinant Protein Drug
    1.5 Industry Overview and Major Regions Status of Recombinant Protein Drug
        1.5.1 Industry Overview of Recombinant Protein Drug
        1.5.2 Global Major Regions Status of Recombinant Protein Drug
    1.6 Industry Policy Analysis of Recombinant Protein Drug
    1.7 Industry News Analysis of Recombinant Protein Drug

2 Manufacturing Cost Structure Analysis of Recombinant Protein Drug
    2.1 Raw Material Suppliers and Price Analysis of Recombinant Protein Drug
    2.2 Equipment Suppliers and Price Analysis of Recombinant Protein Drug
    2.3 Labor Cost Analysis of Recombinant Protein Drug
    2.4 Other Costs Analysis of Recombinant Protein Drug
    2.5 Manufacturing Cost Structure Analysis of Recombinant Protein Drug
    2.6 Manufacturing Process Analysis of Recombinant Protein Drug

3 Technical Data and Manufacturing Plants Analysis of Recombinant Protein Drug
    3.1 Capacity and Commercial Production Date of Global Recombinant Protein Drug Major Manufacturers in 2015
    3.2 Manufacturing Plants Distribution of Global Recombinant Protein Drug Major Manufacturers in 2015
    3.3 R&D Status and Technology Source of Global Recombinant Protein Drug Major Manufacturers in 2015
    3.4 Raw Materials Sources Analysis of Global Recombinant Protein Drug Major Manufacturers in 2015

4 Global Recombinant Protein Drug Overall Market Overview
    4.1 2011-2016E Overall Market Analysis
        4.2.1 2011-2015 Global Recombinant Protein Drug Capacity and Growth Rate Analysis
        4.2.2 2015 Recombinant Protein Drug Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2011-2015 Global Recombinant Protein Drug Sales and Growth Rate Analysis
        4.3.2 2015 Recombinant Protein Drug Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2011-2015 Global Recombinant Protein Drug Sales Price
        4.4.2 2015 Recombinant Protein Drug Sales Price Analysis (Company Segment)
    4.5 Gross Margin Analysis
        4.5.1 2011-2015 Global Recombinant Protein Drug Gross Margin
        4.5.2 2015 Recombinant Protein Drug Gross Margin Analysis (Company Segment)

5 Recombinant Protein Drug Regional Market Analysis
    5.1 North America Recombinant Protein Drug Market Analysis
        5.1.1  North America Recombinant Protein Drug  Market Overview
        5.1.2  North America 2011-2016E Recombinant Protein Drug Local Supply, Import, Export, Local Consumption Analysis
        5.1.3  North America 2011-2016E Recombinant Protein Drug Sales Price Analysis
        5.1.4  North America 2015 Recombinant Protein Drug Market Share Analysis
    5.2 Europe Recombinant Protein Drug Market Analysis
        5.2.1  Europe Recombinant Protein Drug  Market Overview
        5.2.2  Europe 2011-2016E Recombinant Protein Drug Local Supply, Import, Export, Local Consumption Analysis
        5.2.3  Europe 2011-2016E Recombinant Protein Drug Sales Price Analysis
        5.2.4  Europe 2015 Recombinant Protein Drug Market Share Analysis
    5.3 Japan Recombinant Protein Drug Market Analysis
        5.3.1  Japan Recombinant Protein Drug  Market Overview
        5.3.2  Japan 2011-2016E Recombinant Protein Drug Local Supply, Import, Export, Local Consumption Analysis
        5.3.3  Japan 2011-2016E Recombinant Protein Drug Sales Price Analysis
        5.3.4  Japan 2015 Recombinant Protein Drug Market Share Analysis
    5.4 China Recombinant Protein Drug Market Analysis
        5.4.1  China Recombinant Protein Drug  Market Overview
        5.4.2  China 2011-2016E Recombinant Protein Drug Local Supply, Import, Export, Local Consumption Analysis
        5.4.3  China 2011-2016E Recombinant Protein Drug Sales Price Analysis
        5.4.4  China 2015 Recombinant Protein Drug Market Share Analysis
    5.5 Southeast Asia Recombinant Protein Drug Market Analysis
        5.5.1  Southeast Asia Recombinant Protein Drug  Market Overview
        5.5.2  Southeast Asia 2011-2016E Recombinant Protein Drug Local Supply, Import, Export, Local Consumption Analysis
        5.5.3  Southeast Asia 2011-2016E Recombinant Protein Drug Sales Price Analysis
        5.5.4  Southeast Asia 2015 Recombinant Protein Drug Market Share Analysis
    5.6 India Recombinant Protein Drug Market Analysis
        5.6.1  India Recombinant Protein Drug  Market Overview
        5.6.2  India 2011-2016E Recombinant Protein Drug Local Supply, Import, Export, Local Consumption Analysis
        5.6.3  India 2011-2016E Recombinant Protein Drug Sales Price Analysis
        5.6.4  India 2015 Recombinant Protein Drug Market Share Analysis

6 Global 2011-2016E Recombinant Protein Drug Segment Market Analysis (by Type)
    6.1 Global 2011-2016E Recombinant Protein Drug Sales by Type
    6.2 Different Types Recombinant Protein Drug Product Interview Price Analysis
    6.3 Different Types Recombinant Protein Drug Product Driving Factors Analysis
        6.3.1 Recombinant Insulin Recombinant Protein Drug Growth Driving Factor Analysis
        6.3.2 Recombinant Human Interferon (rhIFN) Recombinant Protein Drug Growth Driving Factor Analysis
        6.3.3 Recombinant Human Erythropoietin (rhEPO) Recombinant Protein Drug Growth Driving Factor Analysis
        6.3.4 Recombinant Human Granulocyte Colony-stimulating Factor (rhG-CSF) Recombinant Protein Drug Growth Driving Factor Analysis
        6.3.5 Recombinant Human Growth Hormone (rhGH) Recombinant Protein Drug Growth Driving Factor Analysis
        6.3.6 Recombinant Human Follicle-stimulating Hormone (rhFSH) Recombinant Protein Drug Growth Driving Factor Analysis
        6.3.7 Others Recombinant Protein Drug Growth Driving Factor Analysis

7 Global 2011-2016E Recombinant Protein Drug Segment Market Analysis (by Application)
    7.1 Global 2011-2016E  Consumption by Application
    7.2 Different Application  Product Interview Price Analysis
    7.3 Different Application  Product Driving Factors Analysis
        7.3.1 Hospital use Recombinant Protein Drug Growth Driving Factor Analysis
        7.3.2 Clinic use Recombinant Protein Drug Growth Driving Factor Analysis
        7.3.3 Household Recombinant Protein Drug Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Recombinant Protein Drug
    8.1 Novo Nordisk
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
        8.1.3 Novo Nordisk 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Novo Nordisk 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.2 Amgen
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
        8.2.3 Amgen 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Amgen 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.3 Sanofi
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
        8.3.3 Sanofi 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Sanofi 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.4 Eli Lilly
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
        8.4.3 Eli Lilly 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Eli Lilly 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.5 Merck Serono
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
        8.5.3 Merck Serono 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Merck Serono 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.6 Ortho Biotech
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
        8.6.3 Ortho Biotech 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Ortho Biotech 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.7 Roche
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
        8.7.3 Roche 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Roche 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.8 Kyowa Hakko Kirin
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
        8.8.3 Kyowa Hakko Kirin 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Kyowa Hakko Kirin 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.9 Pharmingen
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
        8.9.3 Pharmingen 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Pharmingen 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.10 Abcam
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
        8.10.3 Abcam 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Abcam 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.11 GenSci
        8.11.1 Company Profile
        8.11.2 Product Picture and Specifications
        8.11.3 GenSci 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.11.4 GenSci 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.12 SL PHARM
        8.12.1 Company Profile
        8.12.2 Product Picture and Specifications
        8.12.3 SL PHARM 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.12.4 SL PHARM 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.13 Shenzhen Neptunus Interlong Bio-Technique Co., Ltd.
        8.13.1 Company Profile
        8.13.2 Product Picture and Specifications
        8.13.3 Shenzhen Neptunus Interlong Bio-Technique Co., Ltd. 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.13.4 Shenzhen Neptunus Interlong Bio-Technique Co., Ltd. 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.14 Anhui Anke Biotechnology
        8.14.1 Company Profile
        8.14.2 Product Picture and Specifications
        8.14.3 Anhui Anke Biotechnology 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.14.4 Anhui Anke Biotechnology 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.15 NCPC
        8.15.1 Company Profile
        8.15.2 Product Picture and Specifications
        8.15.3 NCPC 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.15.4 NCPC 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.16 Heng Rui
        8.16.1 Company Profile
        8.16.2 Product Picture and Specifications
        8.16.3 Heng Rui 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.16.4 Heng Rui 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.17 Changchun High & New Technology Industry (Group) Inc
        8.17.1 Company Profile
        8.17.2 Product Picture and Specifications
        8.17.3 Changchun High & New Technology Industry (Group) Inc 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.17.4 Changchun High & New Technology Industry (Group) Inc 2015 Recombinant Protein Drug Business Region Distribution Analysis
    8.18 Livzon Pharmaceutical Group Inc
        8.18.1 Company Profile
        8.18.2 Product Picture and Specifications
        8.18.3 Livzon Pharmaceutical Group Inc 2015 Recombinant Protein Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.18.4 Livzon Pharmaceutical Group Inc 2015 Recombinant Protein Drug Business Region Distribution Analysis

9 Development Trend of Analysis of  Market
    9.1 Global  Market Trend Analysis
        9.1.1 Global 2016-2021  Market Size (Volume and Value) Forecast
        9.1.2 Global 2016-2021  Sales Price Forecast
        9.1.3 Global 2016-2021  Gross Margin Forecast
    9.2  Regional Market Trend
        9.2.1 North America 2016-2021 Recombinant Protein Drug Consumption Forecast
        9.2.2 Europe 2016-2021 Recombinant Protein Drug Consumption Forecast
        9.2.3 Japan 2016-2021 Recombinant Protein Drug Consumption Forecast
        9.2.4 China 2016-2021 Recombinant Protein Drug Consumption Forecast
        9.2.5 Southeast Asia 2016-2021 Recombinant Protein Drug Consumption Forecast
        9.2.6 India 2016-2021 Recombinant Protein Drug Consumption Forecast
    9.3  Market Trend (Product type)
    9.4  Market Trend (Application)

10 Recombinant Protein Drug Marketing Model Analysis
    10.1 Recombinant Protein Drug Regional Marketing Model Analysis
    10.2 Recombinant Protein Drug International Trade Model Analysis
    10.3 Traders or Distributors with Contact Information of Recombinant Protein Drug by Regions
    10.4 Recombinant Protein Drug Supply Chain Analysis

11 Consumers Analysis of Recombinant Protein Drug
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis
    �

12 New Project Investment Feasibility Analysis of Recombinant Protein Drug
    12.1 New Project SWOT Analysis of Recombinant Protein Drug
    12.2 New Project Investment Feasibility Analysis of Recombinant Protein Drug

13 Conclusion of the Global Recombinant Protein Drug Market Professional Survey Report 2016

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.